Global Aptamers Market - Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4388615
  • Report
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 3
The global aptamers market is estimated at USD 1.055 billion for the year 2016 and is expected to reach USD 16.16 billion by 2021, growing at a CAGR of 73% during the forecast period 2016-2021.

Aptamers are used for research and clinical purposes as they bind to proteins of interest, similar to antibodies. Aptamers can bind to any molecule that they are targeted to, such as cancer cells and bacteria, and inactivate them.

Aptamers are easy to produce and do not cause undesirable immunological reactions. They are used as biosensors, therapeutic tools and to regulate the cellular processes. These factors make the aptamers market one of the fastest growing in the pharmaceuticals sector. There are a number of investments being made in their research and development. A number of innovations, such as nanoparticle therapeutics to enhance the activity of aptamers are also witnessing a growing number of applications.

Global Aptamers Market-Market Dynamics

North America, particularly the United States, holds the largest market for aptamers, followed by the European countries. The aptamers market is growing at the fastest rate in the Asia-Pacific because of the large investments and favorable government policies promoting the development of pharmaceutical industries. The increasing number of diseases requiring novel therapeutics (such as AIDS and Alzheimer’s) is driving the aptamers market. Aptamers also offer a number of advantages over antibodies because of their high specificity, higher binding affinity and the ability to not damage the neighboring cells. Some of the factors restraining the use of aptamers are their susceptibility to being digested by enzymes and the slow approval rate by organizations.

The global aptamers market is segmented based on the type (DNA-based, RNA-based, XNA-based and peptide-based), by applications (diagnostic reagents, biosensors, forensics, biodefense, cancer, therapeutics and drug delivery) and by geography (North America, Europe, Asia-Pacific, Middle East & Africa and South America).

Major Companies in the Sector Include:

This Report Offers:

Market analysis for the global aptamers market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global aptamers market.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 History and Developments in Aptamer Research
5.2 Current Market Scenario
5.3 Regulatory Issues related to Aptamer Market
5.4 Porter’s Five Forces
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Consumers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitute Products and Services
5.4.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
6.1 Market Drivers
6.1.1 Technological advancements in aptamers research
6.1.2 High binding affinity and target specificity of aptamers allows them to be used as an alternative to antibodies
6.1.3 Reduced side effects
6.1.4 Aptamers have better storage properties than antibodies
6.1.5 Aptamers follows in vivo testing than in-vitro, which saves on R&D cost and time
6.2 Market Restraints
6.2.1 Aptamers market is emerging and companies are hesitant to take the risk of market introduction
6.2.2 Commercialization of aptamers research
6.3 Opportunities
6.3.1 Aptamers has applications in diagnostics, therapeutics, forensics, and biodefense
6.4 Challenges
6.4.1 Adapters are rapidly cleared from their body due to their small size.
6.4.2 Lack of awareness on aptamers technology
7. Novel Drug Delivery Devices Market Segmentation
7.1 By Type
7.1.1 DNA-based Aptamers
7.1.2 RNA-based Aptamers
7.1.3 XNA-based Aptamers
7.1.4 Peptide Aptamers
7.2 By Applications
7.2.1 Diagnostic Reagents
7.2.2 Biosensors
7.2.3 Forensics
7.2.4 Biodefense
7.2.5 Cancer
7.2.6 Therapeutics
7.2.7 Drug Delivery
7.3 By Geography
7.3.1 North America Canada United States
7.3.2 Europe France Germany Italy Spain United Kingdom Rest of Europe
7.3.3 Asia-Pacific Australia & New Zealand China India Japan South Korea Rest of Asia-Pacific
7.3.4 Rest of the World
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Company Profiles
9.1 Aptagen
9.2 AM Biotechnologies, LLC
9.3 Aptamer Sciences
9.4 Aptamer Solutions Ltd.
9.5 Aptus Biotech S.L.
9.6 Base Pair Biotechnologies, Inc.
9.7 NeoVentures Biotechnology, Inc.
9.8 SomaLogic, Inc.
9.9 TriLink BioTechnologies, Inc.
9.10 Vivonics, Inc.
9.11 Somalogic,
9.12 NOXXAN Pharma AG
10. Analyst Outlook for Investment Opportunities
11. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown